Literature DB >> 25597351

Regulation of the MAPK pathway by raf kinase inhibitory protein.

Drieke Vandamme1, Ana Herrero1, Fahd Al-Mulla2, Walter Kolch3.   

Abstract

The Raf kinase inhibitor protein 1 (RKIP-1) was the first reported endogenous inhibitor of Raf-1-MEK-ERK/MAPK cascade, by interfering with the phosphorylation of MEK by Raf-1. However, RKIP's functions related to the MAPK signaling are far more complex. Newer data indicate that by modulating different protein-protein interactions, RKIP is involved in fine-tuning cell signaling, modulating ERK dynamics, and regulating cross talk between different pathways. Here, we describe the molecular mechanisms by which RKIP controls MAPK signaling at different levels and vice versa and its regulation via feedback phosphorylation. We also focus on several discrepancies and questions that remain, such as the RKIP binding regulation by Raf-1 N-region phosphorylation, the possible B-Raf inhibition, and the effects of RKIP-lipid binding. We also describe how RKIP's role as key signaling modulator of many cell fate decisions leads to the fact that fine control of RKIP activity and regulation is crucial to avoid pathological processes, such as metastasis, pulmonary arterial hypertension, and heart failure.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25597351     DOI: 10.1615/critrevoncog.2014011922

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  10 in total

1.  Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines.

Authors:  Jin Sun Kim; Gwang Hyeon Choi; Yusun Jung; Kang Mo Kim; Se-Jin Jang; Eun Sil Yu; Han Chu Lee
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-01       Impact factor: 4.553

2.  Fisetin, a dietary bioflavonoid, reverses acquired Cisplatin-resistance of lung adenocarcinoma cells through MAPK/Survivin/Caspase pathway.

Authors:  Wenlei Zhuo; Liang Zhang; Yi Zhu; Bo Zhu; Zhengtang Chen
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

3.  Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer.

Authors:  Bingjie Fu; Xiaojing Dou; Miao Zou; Hao Lu; Kaixuan Wang; Qingxia Liu; Yao Liu; Wei Wang; Meihua Jin; Dexin Kong
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

4.  Loss of Raf kinase inhibitor protein expression is associated with human papillomavirus 16 infection in anal tumors.

Authors:  Lucas Tadeu Bidinotto; Carlos A R Véo; Edgar Aleman Loaiza; Guilherme G Ribeiro; Adriana T Lorenzi; Luciana Albina Reis Rosa; Cristina Mendes De Oliveira; José Eduardo Levi; Cristovam Scapulatempo-Neto; Adhemar Longatto-Filho; Rui Manuel Reis
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

5.  Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.

Authors:  Hae Sook Noh; Young-Sool Hah; Ji Hye Ha; Min Young Kang; Sahib Zada; Sun Young Rha; Sang Soo Kang; Hyun Joon Kim; Jae-Yong Park; June-Ho Byun; Jong Ryeal Hahm; Jeong Kyu Shin; Sang-Ho Jeong; Young-Joon Lee; Deok Ryong Kim
Journal:  Oncotarget       Date:  2016-01-26

6.  The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.

Authors:  Hua-Chuan Zheng; Jia-Jie Liu; Jing Li; Ji-Cheng Wu; Lei Yang; Gui-Feng Zhao; Xin Zhao; Hua-Mao Jiang; Ke-Qiang Huang; Zhi-Jie Li
Journal:  Oncotarget       Date:  2017-04-04

Review 7.  Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling.

Authors:  Ana Raquel-Cunha; Diana Cardoso-Carneiro; Rui M Reis; Olga Martinho
Journal:  Cells       Date:  2019-05-10       Impact factor: 6.600

Review 8.  ERK/MAPK signalling pathway and tumorigenesis.

Authors:  Yan-Jun Guo; Wei-Wei Pan; Sheng-Bing Liu; Zhong-Fei Shen; Ying Xu; Ling-Ling Hu
Journal:  Exp Ther Med       Date:  2020-01-15       Impact factor: 2.447

Review 9.  RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer.

Authors:  Maria Gabriela-Freitas; Joana Pinheiro; Ana Raquel-Cunha; Diana Cardoso-Carneiro; Olga Martinho
Journal:  Biomolecules       Date:  2019-11-22

10.  Novel insights from the Plasmodium falciparum sporozoite-specific proteome by probabilistic integration of 26 studies.

Authors:  Lisette Meerstein-Kessel; Jeron Venhuizen; Daniel Garza; Nicholas I Proellochs; Emma J Vos; Joshua M Obiero; Philip L Felgner; Robert W Sauerwein; Marynthe Peters; Annie S P Yang; Martijn A Huynen
Journal:  PLoS Comput Biol       Date:  2021-04-30       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.